James MacKillop Selected Research

James MacKillop Research Topics

Disease

14	Alcoholism (Alcohol Abuse) 12/2023 - 01/2008
10	Substance-Related Disorders (Drug Abuse) 03/2024 - 05/2009
4	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 11/2023 - 08/2019
4	Gambling (Pathological Gambling) 03/2023 - 10/2013
3	Anxiety Disorders (Anxiety Disorder) 01/2022 - 01/2012
3	Antisocial Personality Disorder (Antisocial Personality) 01/2019 - 05/2009
2	Cognitive Dysfunction 05/2024 - 05/2023
2	Chronic Pain 10/2022 - 08/2019
2	Alcohol-Related Disorders 05/2021 - 01/2008
2	Tobacco Use Disorder (Nicotine Dependence) 01/2021 - 11/2019
2	Opioid-Related Disorders (Opiate Addiction) 01/2017 - 01/2016
1	Atrial Fibrillation 04/2024
1	Stroke (Strokes) 04/2024
1	Hemorrhage 04/2024
1	Food Addiction 12/2023
1	Hyperphagia (Overeating) 12/2023
1	Anhedonia 12/2023
1	Heart Failure 11/2023
1	Infections 11/2023
1	Vomiting 06/2023
1	Nausea 06/2023
1	Cannabinoid Hyperemesis Syndrome 06/2023
1	Mental Disorders (Mental Disorder) 05/2023
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 12/2022
1	Pain (Aches) 10/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2021
1	Overweight 01/2021
1	Major Depressive Disorder (Major Depressive Disorders) 10/2020
1	Long Term Adverse Effects 08/2019
1	Multiple Sclerosis 08/2019
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 06/2017
1	Low Back Pain (Lumbago) 01/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2017
1	Narcissistic Personality Disorder 09/2014
1	Schizophrenia (Dementia Praecox) 07/2011
1	Conduct Disorder (Conduct Disorders) 05/2009

Drug/Important Bio-Agent (IBA)

5	Opioid Analgesics (Opioids)IBA 10/2022 - 01/2016
4	CannabidiolIBA 07/2023 - 01/2019
4	Topiramate (Topamax)FDA LinkGeneric 01/2022 - 03/2008
3	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 12/2023 - 05/2021
3	CannabinoidsIBA 01/2022 - 08/2019
2	salicylhydroxamic acid (SHAM)IBA 05/2024 - 05/2023
2	Illicit Drugs (Recreational Drugs)IBA 01/2022 - 10/2020
2	Medical MarijuanaIBA 10/2021 - 10/2020
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2021 - 11/2019
2	Methadone (Dolophine)FDA LinkGeneric 01/2017 - 01/2016
2	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2017 - 01/2016
2	4-aminospiroperidolIBA 01/2015 - 05/2009
2	Opioid Receptors (Opioid Receptor)IBA 01/2013 - 01/2008
2	Naltrexone (ReVia)FDA LinkGeneric 06/2012 - 01/2008
1	AnticoagulantsIBA 04/2024
1	Fentanyl (Sublimaze)FDA LinkGeneric 11/2023
1	Methamphetamine (Desoxyn)FDA LinkGeneric 11/2023
1	Heroin (Diamorphine)IBA 11/2023
1	Dihydrotachysterol (AT 10)IBA 11/2023
1	Capsaicin (Zostrix)FDA Link 06/2023
1	Dopamine AntagonistsIBA 06/2023
1	Therapeutic UsesIBA 05/2023
1	SmokeIBA 12/2022
1	Carbon MonoxideIBA 01/2021
1	SolutionsIBA 01/2021
1	Dronabinol (THC)FDA LinkGeneric 08/2019
1	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 01/2019
1	Varenicline (Chantix)FDA Link 08/2017
1	Genetic Markers (Genetic Marker)IBA 06/2017
1	Opiate AlkaloidsIBA 01/2017
1	APTIBA 01/2017
1	neodymium pyrocatechin disulfonate (NPD)IBA 09/2014
1	Indicators and Reagents (Reagents)IBA 10/2013
1	Cycloserine (Seromycin)FDA Link 01/2012
1	Cocaine (Cocaine HCl)IBA 01/2012
1	N-Methylaspartate (NMDA)IBA 01/2012
1	Nicotine FDA Link 07/2011
1	Anticonvulsants (Antiepileptic Drugs)IBA 04/2009
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2008

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 07/2023 - 07/2008
3	Transcranial Magnetic Stimulation 05/2024 - 01/2018
2	Nicotine Replacement Therapy 03/2023 - 08/2017
2	Transcranial Direct Current Stimulation 11/2018 - 01/2018
1	Therapeutics 04/2024
1	Precision Medicine 03/2024
1	Ambulatory Care (Outpatient Care) 11/2019